Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 Jun 26.
doi: 10.1007/s12072-025-10862-y. Online ahead of print.

Expanding the utility of non-invasive NSBB monitoring in early CSPH and beyond

Haixing Cao #  1 , Kaiyu Bian #  1 , Xiang Ma  2
Affiliations
Comment

Expanding the utility of non-invasive NSBB monitoring in early CSPH and beyond

Haixing Cao et al. Hepatol Int. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: Haixing Cao, Kaiyu Bian and Xiang Ma declare that they have no potential conflicts of interest relevant to this article were reported.

Comment on

References

    1. Giuffre M, Dupont J, Visintin A, et al. Predicting response to non-selective beta-blockers with liver-spleen stiffness and heart rate in patients with liver cirrhosis and high-risk varices. Hepatol Int. 2025;19(2):460–471 - DOI - PubMed
    1. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII - renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959–974 - DOI - PubMed
    1. Villanueva C, Albillos A, Genesca J, et al. beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393(10181):1597–1608 - DOI - PubMed
    1. Marasco G, Dajti E, Ravaioli F, et al. Spleen stiffness measurement for assessing the response to beta-blockers therapy for high-risk esophageal varices patients. Hepatol Int. 2020;14(5):850–857 - DOI - PubMed
    1. Zacharias AP, Jeyaraj R, Hobolth L, Bendtsen F, Gluud LL, Morgan MY. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Cochrane Database Syst Rev. 2018;10(10):CD011510 - PubMed

LinkOut - more resources